AimAlly™ MESSAGING PROGRAM TERMS
|
|
|
NOTICE: The AimAlly™ Messaging Program ("Program") for Aimovig® (erenumab-aooe) is not intended to be a source of medical advice
or care. Please contact your healthcare provider if you have any questions about your medical condition, diagnosis, treatment or care.
|
|
| 1. |
By opting into the AimAlly™ Messaging Program ("Program") for Aimovig® (erenumab-aooe), in which you can receive monthly refill reminders
via text, you consent to receive approximately 3 text messages per month from Amgen. Such messages may include, but are not limited to,
refill reminders, website information, marketing messages, etc. Your mobile service provider is NOT liable for delayed or undelivered messages.
To opt-in to the AimAlly™ Messaging program, visit Aimovig.com and provide the required information including your mobile phone number.
You will receive an opt-in request from 48794 to your mobile phone number. Follow the texting prompts to complete your subscription.
The Program runs on the short code 48794. Amgen will not charge you to use this Program; however, your Wireless Service Provider may
charge for sending and/or receiving messages and for airtime.
|
|
|
| 2. |
To stop receiving text messages, text STOP to 48794. DOING SO WILL ONLY OPT YOU OUT OF THE MESSAGING PROGRAM SMS
COMMUNICATIONS FOR THIS MOBILE PROGRAM; you will remain opted in to any other Amgen text message program(s) to which you
separately opted in.
|
|
|
| 3. |
To request more information or to obtain help, text HELP to 48794.
|
|
|
| 4. |
You represent that you are the account holder for the mobile telephone number(s) that you provide to opt in to the texting program.
|
|
|
| 5. |
You agree to promptly notify Amgen if you change your mobile telephone number. You may notify Amgen of a number change at any time.
Opt out of the program by texting STOP to 48794 and re-enrolling in the program with your new mobile telephone number. You also agree
to indemnify Amgen and parties texting on its behalf in full for all claims, expenses, and damages related to or caused (in whole or in part)
by your failure to notify Amgen and parties texting on its behalf if you change your telephone number, including but not limited to all claims,
expenses, and damages related to or arising under the Telephone Consumer Protection Act.
|
|
|
| 6. |
Message and data rates may apply to each text message sent or received in connection with the texting program, as provided in your
mobile telephone service rate plan, in addition to any applicable roaming charges. Charges are both billed and payable to your mobile
service provider or deducted from your prepaid account. Amgen does not impose a separate fee for sending text messages.
|
|
|
| 7. |
You understand that data obtained from you by Amgen or its partners, in connection with your registration for, and use of, the Program may
include, for example, your phone number, related carrier information, and device information. This data may be used to administer this
program and to provide program benefits such as refill reminders, as well as program updates and alerts sent directly to your device.
|
|
|
| 8. |
You understand that data obtained from you in connection with your registration for, and use of, the Program may include, for example, your
phone number, related carrier information, and device information. This data may be used to administer this program and to provide
program benefits such as refill reminders, as well as program updates and alerts sent directly to your device. Please read Amgen's full
Privacy Statement, which is incorporated by reference into these Terms.
|
|
|
| 9. |
Amgen will not be liable for any delays in the receipt of any SMS messages, as delivery is subject to effective transmission from your network
operator.
|
|
|
| 10. |
The service is available only on these US participating mobile carriers: Verizon Wireless, Sprint, Nextel, Boost Mobile, T-Mobile, AT&T, Alltel,
ACS Wireless, Bluegrass Cellular, Carolina West Wireless, Cellcom, Cellular One of East Central Illinois (ECIT), Cincinnati Bell, Cricket
Wireless, C Spire Wireless, Duet IP (AKA Max/Benton/Albany), Element Mobile, Epic Touch, GCI Communication, Golden State Cellular,
Hawkeye (Chat Mobility), Hawkeye (NW Missouri Cellular), Illinois Valley Cellular (IVC), Inland Cellular, iWireless, Keystone Wireless (lmmix/PC
Management), MetroPCS, Mobi PCS, Mosaic Telecom, MTPCS/Cellular One (Cellone Nation), Nex-Tech Wireless, nTelos, Panhandle
Telecommunications, Pioneer, Plateau, Revol Wireless, Rina-Custer, Rina-All West, Rina-Cambridge Telecom Coop, Rina-Eagle Valley Comm,
Rina-Farmers Mutual Telephone Co, Rina-Nucla Nutria Telephone Co, Rina-Silver Star, Rina-South Central Comm, Rina-Syringa, Rina-UBET,
Rina-Manti, Simmetry Wireless, South Canaan (Cellular One of NEPA), Thumb Cellular, Union Wireless, United Wireless, U.S. Cellular, Viaero
Wireless, Virgin Mobile, West Central Wireless (includes Five Star Wireless).
|
|
|
| 11. |
You acknowledge that the reliability of the timeliness of Program refill notifications depends upon, the information you provide, which
includes, but is not limited to, phone number and device information, and the functionality of your device. Be sure to accurately provide
information so you receive notifications on time. This Program is not intended to replace the Patient Instructions for Use and any other
information provided to you by your healthcare provider, which are intended to be the sources of information on which you should rely to
understand how to use Aimovig®.
|
|
|
| 12. |
DISCLAIMER: The Program is provided "as is." Amgen and its partners make no warranties, express or implied, regarding the functionality or
accessibility of the Program or the timeliness, contents or reliability of any refill reminders or any other SMS messages, and expressly
disclaim any implied warranty of merchantability or fitness for a particular purpose. To the maximum extent permitted by law, Amgen and its
partners hereby disclaim and will not be liable for any direct, indirect, consequential, special, incidental, punitive or any other damages or
injury arising from or relating in any way to your use of the Program, including but not limited to any costs or expenses or loss of insurance
coverage resulting from non-receipt or untimely receipt of any notifications or inaccessibility of the Program.
|
|
|
| 13. |
Amgen may suspend or terminate your receipt of text messages if it believes you are in breach of these Mobile Program Terms and
Conditions. Your receipt of text messages is also subject to termination in the event that your mobile telephone service terminates or lapses.
Amgen reserves the right to modify or discontinue, temporarily or permanently, all or any part of the text messaging services you receive,
with or without notice.
|
|
|
| 14. |
Amgen may revise, modify, or amend these Mobile Program Terms and Conditions at any time. Any such revision, modification, or
amendment shall take effect when it is posted to Amgen's website. You agree to review these Mobile Program Terms and Conditions
periodically to ensure that you are aware of any changes. Your continued consent to receive text messages will indicate your acceptance of
those changes.
|
|
|
IMPORTANT SAFETY INFORMATION
|
|
Who should not use Aimovig®?
|
|
|
Do not use Aimovig® if you are allergic to erenumab-aooe or any ingredients in Aimovig®.
|
|
|
Before starting Aimovig®, tell your healthcare provider (HCP) about all your medical conditions, including if you are pregnant or plan to become
pregnant, breastfeeding or plan to breastfeed.
|
|
|
Tell your HCP about all the medicines you take, including any prescription and over-the-counter medicines, vitamins, or herbal supplements.
|
|
What are possible side effects of Aimovig®?
|
|
Aimovig® may cause serious side effects, including:
|
|
| • |
Allergic reactions. Allergic reactions, including rash or swelling can happen after receiving Aimovig®. This can happen within hours to days after
using Aimovig®. Call your HCP or get emergency medical help right away if you have any of the following symptoms of an allergic reaction:
swelling of the face, mouth, tongue or throat, or trouble breathing.
|
|
|
| • |
Constipation with serious complications. Severe constipation can happen after receiving Aimovig®. In some cases people have been
hospitalized or needed surgery. Contact your HCP if you have severe constipation or constipation associated with symptoms such as severe or
constant belly pain, vomiting, swelling of belly or bloating.
|
|
|
| • |
High blood pressure. High blood pressure or worsening of high blood pressure can happen after receiving Aimovig®. Contact your healthcare
provider if you have an increase in blood pressure.
|
|
|
|
The most common side effects of Aimovig® are pain, redness, or swelling at the injection site and constipation.
|
|
|
These are not all of the possible side effects of Aimovig®. Call your HCP for medical advice about side effects.
|
|
|
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
|
|
|
Click here for the full Prescribing Information and Patient Product Information.
|
|
APPROVED USE
|
|
|
Aimovig® (erenumab-aooe) is a prescription medicine used for the preventive treatment of migraine in adults.
|
|
